Hey, Novartis is hiring! (Isn’t it tempting?)
Swiss pharmaceutical giant Novartis said Tuesday that it is consolidating its U.S.-based eye disease research projects in Cambridge, Mass., and closing the Novartis Institutes for BioMedical Research group on its Alcon Labs campus in Fort Worth. About 120 employees in Fort Worth were told that their jobs will end June 11, said Dave Jackson, an Alcon spokesman. They will be allowed to apply for jobs in Cambridge and for other Alcon positions, he said. “Alcon’s research and development operations in Fort Worth, focused on pharmaceutical development and formulation as well as medical device research and development, will continue to operate with its full workforce of approximately 950 associates,” Jackson said. The Novartis Institutes for BioMedical Research has 1,600 scientists in Cambridge, he said. Researchers who do not move to Cambridge or do not apply for jobs in Fort Worth will be eligible for a severance package, Jackson said.
Don’t forget, Novartis is hiring! (We know you can’t resist.)
